美国血液技术（Haemonetics，股票代码：HAE）今日盘中大涨5.04%，引起市场广泛关注。这波涨势主要受到公司最新公布的季度财报超出市场预期的推动。
据报道，Haemonetics公布的截至2025年3月31日的季度调整后每股收益为1.24美元，高于分析师平均预期的1.22美元，同时也远超去年同期的0.90美元。公司季度营收达到3.306亿美元，略高于分析师预期的3.2938亿美元，尽管同比下降了3.7%。这一业绩表现显示出公司在当前经济环境下仍保持着良好的盈利能力。
值得注意的是，华尔街分析师对Haemonetics保持积极态度。目前，分析师对该公司股票的平均评级为"买入"，其中8个为"强烈买入"或"买入"，1个为"持有"，1个为"卖出"或"强烈卖出"。分析师给出的12个月目标价中位数为97.50美元，进一步反映了市场对公司未来发展前景的信心。这些积极因素共同推动了今日Haemonetics股价的强劲表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.